Hydrochloric Acid → (S)-1-(4-(6-(3-aminopiperidin-1-yl)pyridin-3-ylamino)-6-(3,5-dichloro-4-hydroxyphenyl)quinolin-3-yl)propan-1-one

HRID 2271858Notes

Reaction equation

[Cl:1][C:2]1[CH:3]=[C:4]([C:10]2[CH:11]=[C:12]3[C:17](=[CH:18][CH:19]=2)[N:16]=[CH:15][C:14]([C:20](=[O:23])[CH2:21][CH3:22])=[C:13]3[NH:24][C:25]2[CH:26]=[CH:27][C:28]([N:31]3[CH2:36][CH2:35][CH2:34][C@H:33]([NH:37]C(=O)OC(C)(C)C)[CH2:32]3)=[N:29][CH:30]=2)[CH:5]=[C:6]([Cl:9])[C:7]=1[OH:8].Cl>>[NH2:37][C@H:33]1[CH2:34][CH2:35][CH2:36][N:31]([C:28]2[N:29]=[CH:30][C:25]([NH:24][C:13]3[C:12]4[C:17](=[CH:18][CH:19]=[C:10]([C:4]5[CH:3]=[C:2]([Cl:1])[C:7]([OH:8])=[C:6]([Cl:9])[CH:5]=5)[CH:11]=4)[N:16]=[CH:15][C:14]=3[C:20](=[O:23])[CH2:21][CH3:22])=[CH:26][CH:27]=2)[CH2:32]1

Participants

Reactant 2

HCID 313Hydrochloric Acid

HCID 86692977(S)-tert-butyl 1-(5-(6-(3,5-dichloro-4-hydroxyphenyl)-3-propionylquinolin-4-ylamino)pyridin-2-yl)piperidin-3-ylcarbamate

Product 1

HCID 86692978(S)-1-(4-(6-(3-aminopiperidin-1-yl)pyridin-3-ylamino)-6-(3,5-dichloro-4-hydroxyphenyl)quinolin-3-yl)propan-1-oneYield 86.5%

Procedure

Following general procedure A, (S)-tert-butyl 1-(5-(6-(3,5-dichloro-4-hydroxyphenyl)-3-propionylquinolin-4-ylamino)pyridin-2-yl)piperidin-3-ylcarbamate (50 g, 0.078 mmol) was treated with a solution of 3N HCl to afford desired product (36.2 mg, 72%) as a yellow-orange solid: 1H NMR (500 MHz, MeOD) δ 9.29 (s, 1H), 8.25 (m, 2H), 8.05 (m, 2H), 7.85 (d, J=8.8 Hz, 1H), 7.31 (m, 3H), 4.52 (s, 1H), 4.06 (d, J=12.6 Hz, 1H), 3.81 (m, 3H); 2.16 (q, J=7.0 Hz, 2H), 2.22 (s, 1H), 1.98 (s, 1H), 1.24 (t, J=7.0 Hz, 3H); APCI MS m/z 536 [C28H27Cl2N5O2+H]+; HPLC 98.7% (AUC), tR=10.30 min.

Sources & evidence

ORD record: ord-19543f6dc24447b3a08043f7c9ce3cb7
Source dataset: uspto-grants-2015_09
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US09120749B2

Reaction notes

Loading…